PATENT CLAIM ANALYSIS

Application Number: 15960709
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "400000"]

Abstract:
This disclosure provides pharmaceutical adenovirus formulations, in particular, liquid pharmaceutical formulations comprising adenoviruses.

Claim (Index 31):
A method of preserving a recombinant adenovirus, the method comprising:\n a. preparing a recombinant adenovirus formulation, wherein the formulation comprises:\n i. a recombinant adenovirus; \n ii. a citrate buffer having a concentration of between about 5 mM and about 30 mM; \n iii. hydroxypropyl-beta-cyclodextrin (HBCD); \n iv. a salt; and \n v. a non-ionic detergent;\n wherein said formulation has a pH of between about 5.5 and about 6.5, and \n wherein the formulation is a liquid formulation, and \n \n b. storing said formulation at between about 2\u00b0 C. and about 8\u00b0 C., wherein storing the formulation at between about 2\u00b0 C. and about 8\u00b0 C. preserves the recombinant adenovirus.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.23077
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14916539', '11071095', '10791503', '14988138', '14208919']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7082584316624616
- 35 USC 102 Novelty (BERT): 0.6370300607400653
- Combined Prediction Score: 0.701135594570222
- Mean Citation Score: 320.70632599999993
- Max Citation Score: 602.6609
- Similarity Product: 559.9170335912229

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test